Category:Dihydrofolate reductase inhibitors
These agents inhibit the enzyme dihydrofolate reductase, an important rate-limiting step in the de novo folate synthesis pathway. Methotrexate is a cancer chemotherapeutic agent, whilst trimethoprim is an antibiotic. The reason for this disparity, despite both being dihydrofolate reductase inhibitors, is that methotrexate has a selective affinity for mammalian dihydrofolate reductase, while trimethoprim has a selective affinity for the bacterial enzyme.
|Wikimedia Commons has media related to Dihydrofolate reductase inhibitors.|
This category has the following 4 subcategories, out of 4 total.